USBio Logo

D8077-02 Docetaxel CAS: 114977-28-5

Specifications
References
CAS Number
114977-28-5
Grade
Highly Purified
Molecular Formula
C43H53NO14
Molecular Weight
807.88
EU Commodity Code
38220090
Shipping Temp
RT
Storage Temp
-20°C
Docecad; N-debenzoyl-N-tert-butoxycarbonyl-10-deacetyltaxol; NSC 628503; RP 56976; Taxoltere metro; docetaxol; Taxotere

An antineoplastic. An antimitotic agent that promotes the assembly of microtublules and inhibits their depolymerization to free tubulin. Docetaxel is of the chemotherapy drug class; taxane, and is a semi-synthetic analogue of paclitaxel (Taxol), an extract from the bark of the rare Pacific yew tree Taxus brevifolia. Due to scarcity of paclitaxel, extensive research was carried out leading to the formulation of docetaxel – an esterified product of 10-deacetyl baccatin III, which is extracted from the renewable and more readily available leaves of the European yew tree. Docetaxel differs from paclitaxel at two positions in its chemical structure. It has a hydroxyl functional group on carbon 10, whereas paclitaxel has an acetate ester, and a tert-butyl carbamate ester exists on the phenylpropionate side chain instead of the benzamide in paclitaxel. The carbon 10 functional group change causes docetaxel to be more water-soluble than paclitaxel.

Synonyms
Docecad; N-debenzoyl-N-tert-butoxycarbonyl-10-deacetyltaxol; NSC 628503; RP 56976; Taxoltere metro; docetaxol; Taxotere
CAS No
114977-28-5
Molecular Formula
C43H53NO14
Molecular Weight
807.88
Purity
≥99% (HPLC, TLC)
Appearance
White powder
Melting Point
186-192°C
Calculated
C 61.94% H 6.79% N 1.67%
Solubility
Soluble in DMSO at 200mg/ml. Soluble in ethanol at 100mg/ml. Very poorly soluble in water. Maximum solubility in plain water is estimated to be about 10-20uM.
Storage and Stability
Store at -20°C under inert atmosphere. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Important Note
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Toxicity and Hazards
 All products should be handled by qualified personnel only, trained in laboratory procedures.
References
1. Ringel, I., et al.: J. Natl. Cancer Inst., 83, 288 (1991). 2. Extra, J.-M., et al. Cancer Res., 53, 1037 (1993). 3. Pienta, K.J. "Preclinical mechanisms of action of docetaxel and docetaxel combinations in prostate cancer." Semin Oncol. 4: 3-7 (2001). 4. Yoshida, K., et al. "Phase I study of combination therapy with S-1 and docetaxel (TXT) for advanced or recurrent gastric cancer." Anticancer Res. 24: 1843-1851 (2004). 5. Tabernero, J., et al. "A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer." Ann Oncol. 15: 1358-1365 (2004).
USBio References
No references available
Pricing
Order
Proceed to Checkout
Cart Summary
ProductSizeListYour PriceQtyExt Price
Subtotal:Subtotal:
Subtotal:Subtotal:
Total Coupon Savings:Total Coupon Savings:()
Your cart is currently empty.
- Coupon Code
Recently Viewed
  • Contact Us

    Visit our technical library or contact our support staff to answer your questions.

    Telephone:
    1-800-520-3011

    Library | Contact

    Distributors

    For customers outside of the United States, please use one of our many distributors.

    View Distributors

    Payment Methods

    We accept the following payment methods as well as pay-by-invoice.

    MasterCard Visa PayPal
    © 2023-2024 United States Biological - All Rights Reserved